Protein Quality Control in Alzheimer's Disease: A Fatal Saviour

Aggregation of A beta plays a key role in the pathogenesis of Alzheimer's disease. Although the highly structured A beta aggregates ( fibrils) have long been thought to be the toxic form of A beta, recent evidence suggests that smaller, soluble intermediates in A beta aggregation are the real culprit. Because these oligomeric aggregates are already formed in the secretory pathway, this raises another issue: Is intra- or extracellular A beta involved in the pathogenic cascade? Because aggregated proteins are very toxic, cells have developed quality control responses to deal with such proteins. A prime site for quality culum. Here, aberrant proteins are recognized and can be targeted for degradation to the cytosolic quality control system. In addition, there is accumulating evidence for quality control in other subcellular compartments in the cell. All quality control mechanisms are initially protective, but will become destructive after prolonged accumulation of aggregated proteins. This is enhanced by decreased efficiency of these systems during aging and therefore, these responses may play an important role in the pathogenesis of Alzheimer's disease. In this review, we will discuss the role of protein quality control in the neurotoxicity of A beta.